ReviewAdvances in ophthalmology practice and research
Biomechanical contributions to cataract development and implications for treatment strategies.
Review in Advances in ophthalmology practice and research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Mechanical basis of cortical cataract.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Advancing Treatment of Degenerative Eye Diseases at the Nanoscale.Smart medicine · 2026Review
- Lens Biomechanics and Mechanotransduction Signaling: Dual Pillars of Age-Related Cataract Pathogenesis.Investigative ophthalmology & visual science · 2026Review
- Gigantol Preserves Lens Biophysical Homeostasis by Restoring Cytoskeletal Integrity and Membrane Fluidity in a Diabetic Cataract Model.International journal of molecular sciences · 2026Article
- Cataract: Surgery first - is there still room for basic research?Advances in ophthalmology practice and researchReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cataracts remain the leading cause of blindness worldwide, primarily due to the progressive opacification of the crystalline lens. While surgical removal is the only definitive treatment, no pharmacological therapies have proven effective in reversing or significantly delaying disease progression. Main text: Alterations in the biomechanical properties of the lens and their role in cataract formation. Biomechanics plays a crucial role in maintaining the normal structure and function of living organisms. As a mechanical material, the lens is subject to long-term regulation by the ciliary body, with its mechanical deformability being closely linked to the function of visual accommodation. Additionally, with age, the mechanical properties of the lens and its components undergo gradual changes, resulting in increased stiffness, reduced elasticity, and impaired accommodative capacity. These changes highlight the potential role of lens biomechanics in the onset and progression of cataracts. Understanding the patterns of biomechanical alterations during cataract formation may improve early diagnosis, enable better prediction of disease progression, optimize surgical approaches, and contribute to the development of non-surgical interventions, including pharmacological therapies and novel intraocular lens designs. Conclusions: Focusing on biomechanical changes during the onset and progression of cataracts is essential for the development of new diagnostic and therapeutic strategies. This paper provides an overview of the anatomical structure of the lens, reviews existing literature on age-related biomechanical changes in the lens and their direct link to cataract pathogenesis, and discusses future research directions and applications of biomechanics in cataract research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.